Search details
1.
Efficacy and safety of everolimus plus exemestane in patients with hormone receptor-positive, HER-2-negative advanced breast cancer: Results from the open-label, multicentre, non-interventional BRAWO study.
Int J Cancer
; 155(1): 128-138, 2024 Jul 01.
Article
in English
| MEDLINE | ID: mdl-38447007
2.
Impact of stromal tumor-infiltrating lymphocytes (sTILs) on response to neoadjuvant chemotherapy in triple-negative early breast cancer in the WSG-ADAPT TN trial.
Breast Cancer Res
; 24(1): 58, 2022 09 02.
Article
in English
| MEDLINE | ID: mdl-36056374
3.
PIK3CA-mutations in breast cancer.
Breast Cancer Res Treat
; 196(3): 483-493, 2022 Dec.
Article
in English
| MEDLINE | ID: mdl-36279023
4.
[Predictors of the Utilization and Waiting Period Before Starting an Oncological Rehabilitation after Breast Cancer]. / Prädiktoren der Inanspruchnahme und des Beginns einer onkologischen Rehabilitation nach Brustkrebs.
Rehabilitation (Stuttg)
; 60(2): 86-94, 2021 Apr.
Article
in German
| MEDLINE | ID: mdl-33858017
5.
Efficacy of deescalated chemotherapy according to PAM50 subtypes, immune and proliferation genes in triple-negative early breast cancer: Primary translational analysis of the WSG-ADAPT-TN trial.
Int J Cancer
; 146(1): 262-271, 2020 01 01.
Article
in English
| MEDLINE | ID: mdl-31162838
6.
Proteomic profiling of breast cancer metabolism identifies SHMT2 and ASCT2 as prognostic factors.
Breast Cancer Res
; 19(1): 112, 2017 Oct 11.
Article
in English
| MEDLINE | ID: mdl-29020998
7.
Correction: Long-term Follow-up and Safety of Patients after an Upfront Therapy with Letrozole for Early Breast Cancer in Routine Clinical Care - The PreFace Study.
Geburtshilfe Frauenheilkd
; 84(2): e10, 2024 Feb.
Article
in English
| MEDLINE | ID: mdl-38690326
8.
Long-term Follow-up and Safety of Patients after an Upfront Therapy with Letrozole for Early Breast Cancer in Routine Clinical Care - The PreFace Study.
Geburtshilfe Frauenheilkd
; 84(2): 185-195, 2024 Feb.
Article
in English
| MEDLINE | ID: mdl-38344045
9.
PRECYCLE: multicenter, randomized phase IV intergroup trial to evaluate the impact of eHealth-based patient-reported outcome (PRO) assessment on quality of life in patients with hormone receptor positive, HER2 negative locally advanced or metastatic breast cancer treated with palbociclib and an aromatase inhibitor or palbociclib and fulvestrant.
Trials
; 24(1): 338, 2023 May 17.
Article
in English
| MEDLINE | ID: mdl-37198674
10.
Endometrial Cancer. Guideline of the DGGG, DKG and DKH (S3-Level, AWMF Registry Number 032/034-OL, September 2022). Part 1 with Recommendations on the Epidemiology, Screening, Diagnosis and Hereditary Factors of Endometrial Cancer, Geriatric Assessment and Supply Structures.
Geburtshilfe Frauenheilkd
; 83(8): 919-962, 2023 Aug.
Article
in English
| MEDLINE | ID: mdl-37588260
11.
Prognostic Value of Tumour-Infiltrating Lymphocytes in an Unselected Cohort of Breast Cancer Patients.
Diagnostics (Basel)
; 12(10)2022 Oct 18.
Article
in English
| MEDLINE | ID: mdl-36292215
12.
Endocrine Therapy Response and 21-Gene Expression Assay for Therapy Guidance in HR+/HER2- Early Breast Cancer.
J Clin Oncol
; 40(23): 2557-2567, 2022 08 10.
Article
in English
| MEDLINE | ID: mdl-35404683
13.
De-escalated Neoadjuvant Chemotherapy in Early Triple-Negative Breast Cancer (TNBC): Impact of Molecular Markers and Final Survival Analysis of the WSG-ADAPT-TN Trial.
Clin Cancer Res
; 28(22): 4995-5003, 2022 11 14.
Article
in English
| MEDLINE | ID: mdl-35797219
14.
Identifying High-Risk Triple-Negative Breast Cancer Patients by Molecular Subtyping.
Breast Care (Basel)
; 16(6): 637-647, 2021 Dec.
Article
in English
| MEDLINE | ID: mdl-35082572
15.
Immune cell composition and functional marker dynamics from multiplexed immunohistochemistry to predict response to neoadjuvant chemotherapy in the WSG-ADAPT-TN trial.
J Immunother Cancer
; 9(5)2021 05.
Article
in English
| MEDLINE | ID: mdl-33963012
16.
Update Breast Cancer 2021 Part 1 - Prevention and Early Stages.
Geburtshilfe Frauenheilkd
; 81(5): 526-538, 2021 May.
Article
in English
| MEDLINE | ID: mdl-34035547
17.
Update Breast Cancer 2021 Part 2 - Advanced Stages, Long-Term Consequences and Biomarkers.
Geburtshilfe Frauenheilkd
; 81(5): 539-548, 2021 May.
Article
in English
| MEDLINE | ID: mdl-34035548
18.
Specific allelic variants of SNPs in the MDM2 and MDMX genes are associated with earlier tumor onset and progression in Caucasian breast cancer patients.
Oncotarget
; 10(20): 1975-1992, 2019 Mar 08.
Article
in English
| MEDLINE | ID: mdl-30956778
19.
West German Study PlanB Trial: Adjuvant Four Cycles of Epirubicin and Cyclophosphamide Plus Docetaxel Versus Six Cycles of Docetaxel and Cyclophosphamide in HER2-Negative Early Breast Cancer.
J Clin Oncol
; 37(10): 799-808, 2019 04 01.
Article
in English
| MEDLINE | ID: mdl-30785826
20.
Comparison of Neoadjuvant Nab-Paclitaxel+Carboplatin vs Nab-Paclitaxel+Gemcitabine in Triple-Negative Breast Cancer: Randomized WSG-ADAPT-TN Trial Results.
J Natl Cancer Inst
; 110(6): 628-637, 2018 06 01.
Article
in English
| MEDLINE | ID: mdl-29228315